Benzinga | Aug 9, 2021 07:36AM EDT

bluebird bio Q2 EPS $(3.43) Misses $(3.19) Estimate, Sales $7.47M Miss $19.68M Estimate

bluebird bio (NASDAQ:BLUE) reported quarterly losses of $(3.43) per share which missed the analyst consensus estimate of $(3.19) by 7.52 percent. This is a 852.78 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $7.47 million which missed the analyst consensus estimate of $19.68 million by 62.03 percent. This is a 96.24 percent decrease over sales of $198.89 million the same period last year.